Sort
51,593 grants matching “hepatitis”
KLF14 and Atherosclerosis
$702,356Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2017 · HL
Structurally dissecting APOBEC3's for HIV-1 restriction and beyond
$702,264Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$702,234James L. Sorensen · University Of California, San Francisco · UG1 · FY2017 · DA
Vascular delivery of nanocarriers by erythrocyres
$702,164Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2021 · HL
A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment among Young Adult People who Inject Drugs
$702,136Meghan D Morris · University Of California, San Francisco · R01 · FY2025 · DA
HIV Disease Outcomes in Drug Users in Clinical Practice
$702,056Richard Douglas Moore · Johns Hopkins University · R01 · FY2011 · DA
Quantitative studies of metabolic organ dynamics
$701,924Richard N. Bergman · Cedars-Sinai Medical Center · R01 · FY2022 · DK
Nuclear receptors: action, functions, and roles in disease
$701,864Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Interactions between diverse brain cell types drive Aicardi-Goutieres neuropathology
$701,778Mariko L. Bennett · Children'S Hosp Of Philadelphia · R01 · FY2024 · NS
Intervention for Sustained Testing and Retention (iSTAR) Among HIV-infected Patients
$701,573Echezona Edozie Ezeanolue · University Of Nevada Las Vegas · R01 · FY2016 · HD
Gene Expression and Manipulation of Coxiella Burnetii
$701,535Michael F Minnick · Colorado State University · U54 · FY2008 · AI
Cholesterol toxicity in alcohol-associated hepatitis
$701,450Zhenghui Gordon Jiang · Beth Israel Deaconess Medical Center · R01 · FY2023 · AA
Clinical Core
$701,446Cornelia L Dekker · Stanford University · U19 · FY2017 · AI
Hepatic gene transfer for the treatment of hemophilia B and other genetic diseases
$701,310Mark A Kay · Stanford University · R01 · FY2025 · HL
Hepatic gene transfer for the treatment of hemophilia B and other genetic diseases
$701,277Mark A Kay · Stanford University · R01 · FY2024 · HL
Gluconeogenesis and Glycogenolysis - Role and Regulation
$701,229Alan D Cherrington · Vanderbilt University · R01 · FY2011 · DK
Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid
$701,221Charles J Neighbors · New York University School Of Medicine · R33 · FY2020 · DA
Alcohol Metabolism, Functional Consequence And Signaling Mechanism
$701,205Byoung-Joon Song · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
$701,186Mark John Ranek · Johns Hopkins University · R01 · FY2024 · HL
Innate immune dysregulation in alcohol-associated liver disease
$701,051Gyongyi Szabo · Beth Israel Deaconess Medical Center · R01 · FY2025 · AA
HEPATITIS C: STUDIES OF IMMUNITY AND PATHOGENESIS
$701,031Rockefeller University · U19 · FY2002 · AI
Stroke with Transfusions Changing to Hydroxyurea (SWITCH) Trial Data Coordinating
$701,016Rho Federal Systems Division, Inc. · U01 · FY2005 · HL
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$700,991Douglas K Owens · Stanford University · R37 · FY2025 · DA
Epidemiology of Helicobacter Pylori Transmission
$700,789Julie Parsonnet · Stanford University · R01 · FY2010 · AI
Data-Driven Mathematical and Computational Modeling of Hepatitis D Infection and Treatment Response
$700,720Harel Dahari · Loyola University Chicago · R01 · FY2024 · AI